Back
ESC Professional Premium Access

Utility of Soluble ST2 biomarker to predict recurrence after electrical cardioversion in patients with atrial fibrillation

Session: Following disease progression by blood biomarkers
Topic: Biomarkers
Speaker: Doctor L. Gonzalez-Melchor (Lugo, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Laila Gonzalez-Melchor

Lucus Augusti University Hospital, Lugo (Spain)
0 follower

6 more presentations in this session

Coronary artery disease ameliorates extracellular vesicle lncRNA PUNISHER regulates angiogenic response and endothelial cells function via NFkB-dependent mechanism

Speaker: Doctor M. Hosen (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography

Speaker: Doctor K. Ali (Dundee, GB)

Access
Abstract
Slides
Like
Thumbnail

The endoplasmic reticulum (ER) chaperone GRP78 is secreted during ER Stress and alleviates endothelial cell inflammation

Speaker: Miss E. Repges (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Metabolic modulation as a common adaptive mechanism in patients with different subtypes of aortic valve stenosis

Speaker: Doctor P. Bengel (Giessen, DE)

Access
Abstract
Slides
Like
Thumbnail

Cardiac troponin T degradation in end-stage renal disease patients appears to occur in vivo

Speaker: Miss E. Denessen (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Following disease progression by blood biomarkers

Speakers: Doctor L. Gonzalez-Melchor, Doctor M. Hosen, Doctor K. Ali, Miss E. Repges, Doctor P. Bengel...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources